Differential proteome analysis of serum proteins associated with the development of type 2 diabetes mellitus in the KK-A(y) mouse model using the iTRAQ technique.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Proteomics

• Publication date

  2013-06-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jprot.2013.03.014PMID 23545169
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced Nrf2 Activity Worsens Insulin Resistance, Impairs Lipid Accumulation in Adipose Tissue, and Increases Hepatic Steatosis in Leptin-Deficient Mice

  2012cited by this paper
• iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes.

  2012cited by this paper
• Pyridoxamine, an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese, type 2 diabetic mice.

  2010cited by this paper
• Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients

  2010cited by this paper
• Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family

  2010cited by this paper
• Anti-inflammatory and antioxidant effects of SERPINA3K in the retina.

  2009cited by this paper
• Bioinformatics analysis of functional protein sequences reveals a role for brain-derived neurotrophic factor in obesity and type 2 diabetes mellitus.

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance–Associated Iron Overload

  2008cited by this paper
• Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients.

  2007cited by this paper
• Serum resistin as a biological marker for coronary artery disease and restenosis in type 2 diabetic patients.

  2007cited by this paper
• Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy

  2007cited by this paper
• Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.

  2007cited by this paper
• Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.

  2007cited by this paper
• Proteomic analysis of tyrosine phosphorylation during human liver transplantation

  2007cited by this paper
• The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes

  2006cited by this paper
• Mining biomarkers in human sera using proteomic tools

  2004cited by this paper
• Macrophages : Activation by Oxidatively Modified Ldl and 4-hydroxynonenal Role of Nrf2 in the Regulation of Cd36 and Stress Protein Expression in Murine

  2004cited by this paper
• A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients.

  2003cited by this paper
• Identification of a Novel Variant in the Phosphoenolpyruvate Carboxykinase Gene Promoter in Japanese Patients with Type 2 Diabetes

  2003cited by this paper
• Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage

  2003cited by this paper
• Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway

  2003cited by this paper
• Diabetes Mellitus in the Era of Proteomics

  2003cited by this paper
• ProteinChip technology: a new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease.

  2002cited by this paper
• Serpin structure, mechanism, and function.

  2002cited by this paper
• Contribution of known and unknown susceptibility genes to early-onset diabetes in scandinavia: evidence for heterogeneity.

  2002cited by this paper
• Identification of functional domains of the extrinsic 12 kDa protein in red algal PSII by limited rroteolysis and directed mutagenesis.

  2001cited by this paper
• Genetics of obesity in KK mouse and effects of Ay allele on quantitative regulation

  1998cited by this paper
• The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity.

  1998cited by this paper
• The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.

  1998cited by this paper
• Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats.

  1997cited by this paper
• The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema.

  1995cited by this paper
• Implications of the Diabetes Control and Complications Trial. American Diabetes Association.

  1993cited by this paper
• Micromotion of mammalian cells measured electrically.

  1991cited by this paper
• Molecular cloning and characterization of rat contrapsin-like protease inhibitor and related proteins.

  1991cited by this paper
• Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats.

  1990cited by this paper
• The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation.

  1987cited by this paper
• Identification of a new tissue-kallikrein-binding protein.

  1986cited by this paper
• Breeding of mice strains for diabetes mellitus

  1969cited by this paper

• SerpinA3k Deficiency Ameliorates Experimental type 2 Diabetes

  2025cites this paper
• Evaluation of Some Proteins as Potential Markers in Different Durations of Diabetic Patients Type 2  

  2025cites this paper
• Association of metabolic evaluation of visceral fat score with nonalcoholic fatty liver disease and liver fibrosis: A cross-sectional study based on NHANES

  2025cites this paper
• Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes

  2025cites this paper
• Role of Serine Protease Inhibitors A1 and A3 in Ocular Pathologies

  2024cites this paper
• Rodent Models of Diabetic Retinopathy as a Useful Research Tool to Study Neurovascular Cross-Talk

  2023cites this paper
• Exploration of the common pathogenic link between COVID‐19 and diabetic foot ulcers: An in silico approach

  2023cites this paper
• A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis

  2022cites this paper
• Identification of Novel Biomarkers for Pre-diabetic Diagnosis Using a Combinational Approach

  2021influential citation
• Identifying Biomarkers from Transcriptomic Signatures in Renal Allograft Biopsies Using Deceased and Living Donors

  2021cites this paper
• Catch-up growth in juvenile rats, fat expansion, and dysregulation of visceral adipose tissue

  2021cites this paper
• Mass Spectrometry‐Based Analysis of Time‐Resolved Proteome Quantification

  2020cites this paper
• Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure

  2020cites this paper
• Urinary afamin levels are associated with the progression of diabetic nephropathy.

  2019cites this paper
• Protective effects of IFN-γ on the kidney of type- 2 diabetic KKAy mice

  2018cites this paper
• Asymmetric dimethylarginine targets MAPK pathway to regulate insulin resistance in liver by activating inflammation factors

  2018cites this paper
• Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling.

  2018cites this paper
• Proteomic analysis of serum biomarkers for prediabetes using the Long‐Evans Agouti rat, a spontaneous animal model of type 2 diabetes mellitus

  2017cites this paper
• Serum Quantitative Proteomic Analysis Reveals Soluble EGFR To Be a Marker of Insulin Resistance in Male Mice and Humans

  2017cites this paper
• A type 2 diabetes-associated SNP in KCNQ1 (rs163184) modulates the binding activity of the locus for Sp3 and Lsd1/Kdm1a, potentially affecting CDKN1C expression

  2017cites this paper
• A novel angiogenic peptide, ΔADT: A truncated adrenotensin peptide revealed by secretory peptidome analysis of human retinal pericytes.

  2016cites this paper
• INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA, A.C. POSGRADO EN CIENCIAS EN BIOLOGÍA MOLECULAR “Título de la tesis”

  2016cites this paper
• Quantitative proteomics analysis to identify diffuse axonal injury biomarkers in rats using iTRAQ coupled LC-MS/MS.

  2016cites this paper
• A proteomic approach to obesity and type 2 diabetes

  2015cites this paper
• 4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-α and regulating the expression of insulin signal transduction proteins

  2015cites this paper
• Quantitative analysis of the murine lipid droplet-associated proteome during diet-induced hepatic steatosis[S]

  2015cites this paper
• A Time-Course Proteomic Analysis of Rice Triggered by Plant Activator BTH

  2015cites this paper
• Perfluorooctanoic acid exposure for 28 days affects glucose homeostasis and induces insulin hypersensitivity in mice

  2015cites this paper